CBIC Clarifies GST Rules on Pre-Packaged Goods and Gene Therapy

The CBIC has clarified GST rules concerning pre-packaged goods and gene therapy. These clarifications aim to ensure better compliance and understanding among businesses operating in these sectors. By detailing the GST implications for pre-packaged goods, the CBIC seeks to eliminate confusion and streamline tax processes. Additionally, the inclusion of gene therapy reflects an adaptive approach to emerging healthcare technologies, ensuring that they are appropriately categorized under the GST framework. This initiative underscores the importance of clarity in tax regulations, promoting compliance and fostering growth in innovative sectors.